Kamura et al evaluated histopathologic risk factors in women with cervical carcinoma treated by radical hysterectomy. This can help identify patients who may require more aggressive therapy. The authors are from Kyushu University in Fukuoka, Japan.
Risk factors:
(1) histologic type
(2) tumor diameter
(3) number of lymph node groups with metastases
|
Histologic Type |
Tumor Diameter |
Number of Lymph Node Groups |
Prognosis |
|
squamous cell |
< 40 mm |
0 |
good |
|
adenocarcinoma |
< 40 mm |
0 |
intermediate |
|
squamous cell |
>= 40 mm |
0 |
intermediate |
|
squamous cell |
< 40 mm |
1 |
intermediate |
|
adenocarcinoma |
>= 40 mm |
0 |
poor |
|
adenocarcinoma |
NA |
1 |
poor |
|
squamous cell |
>= 40 mm |
1 |
poor |
|
NA |
NA |
>= 2 |
poor |
from Table 5, page 184
where:
• The good prognostic group in Table 5 says that the tumor diameter is < 20 mm. However, Table 4 shows a good prognosis for the 20-39 mm diameter group, and this range is not included elsewhere in Table 5.
• There is no entry in Table 5 for adenocarcinoma, size >= 40 mm with no lymph node metastases. In Table 4 this is listed in the poor prognostic group.
|
Prognostic Group |
5 Years Survival (1992) |
7 Year Survival (1992) |
|
good |
96% |
93% |
|
intermediate |
82% |
80% |
|
poor |
64% |
38% |
from Figure 1, page 185.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
ICD-10: ,
